Douglas Connect is pleased to present the following seminar with audio which is available for viewing on the KM in Pharma and Life Sciences CoP website. Please log into innovationwell.net to access.
KM and Strategies to Nurture Innovating
Victor Newman, Pfizer
Efficiency is no substitute for effectiveness. We need to go back to understanding innovating behaviour, otherwise we may get trapped within intellectual boxes of our own devising that lead to us reinforcing failing strategies with more monkeys and even more typewriters.
In this seminar Victor Newman addresses:
-The futility of retrospective ROI strategies
-K2 or the Knowledge about Knowledge Management required within the R&D context necessary to deliver new market value
-Creativity and "Innovating" rather than innovation
-Exploiting the power of the Innovating Behaviours Portfolio to put knowledge to work
The presentation is followed by an extensive interview and Q&A between Barry Hardy, KM in Pharma & Life Sciences Community of Practice Manager, and Victor Newman on the application of these concepts within the pharma industry.